{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"CASI Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"CASI"},"Address":{"label":"Address","value":"9620 MEDICAL CENTER DRIVE,SUITE 300, ROCKVILLE, Maryland, 20850, United States"},"Phone":{"label":"Phone","value":"+1 240 864-2600"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing innovative therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA. The company primarily operates in the United States, Canada, China and other parts of the world."},"CompanyUrl":{"label":"Company Url","value":"https://www.casipharmaceuticals.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexander Anthony Zukiwski","title":"Global Chief Medical Officer & Executive VP"},{"name":"Chun Hua Wang","title":"Chief Operation Officer"},{"name":"Wei Wu He","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}